| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Antisense oligonucleotides as a tool for gene functionalization and target validation
|
Bennett, C.Frank
|
|
1999
|
1489 |
1 |
p. 19-30
12 p.
|
article
|
| 2 |
Antisense properties of peptide nucleic acid
|
Larsen, H.Jakob
|
|
1999
|
1489 |
1 |
p. 159-166
8 p.
|
article
|
| 3 |
A review of issues in the pharmacokinetics and toxicology of phosphorothioate antisense oligonucleotides
|
Levin, Arthur A
|
|
1999
|
1489 |
1 |
p. 69-84
16 p.
|
article
|
| 4 |
2′-Carbohydrate modifications in antisense oligonucleotide therapy: importance of conformation, configuration and conjugation
|
Manoharan, Muthiah
|
|
1999
|
1489 |
1 |
p. 117-130
14 p.
|
article
|
| 5 |
Conformationally restricted carbohydrate-modified nucleic acids and antisense technology
|
Herdewijn, P.
|
|
1999
|
1489 |
1 |
p. 167-179
13 p.
|
article
|
| 6 |
Human Bcl-2 antisense therapy for lymphomas
|
Cotter, Finbarr E
|
|
1999
|
1489 |
1 |
p. 97-106
10 p.
|
article
|
| 7 |
Importance of nucleotide sequence and chemical modifications of antisense oligonucleotides
|
Agrawal, Sudhir
|
|
1999
|
1489 |
1 |
p. 53-67
15 p.
|
article
|
| 8 |
Mechanisms and applications of immune stimulatory CpG oligodeoxynucleotides
|
Krieg, Arthur M.
|
|
1999
|
1489 |
1 |
p. 107-116
10 p.
|
article
|
| 9 |
Molecular mechanisms of action of antisense drugs
|
Crooke, Stanley T
|
|
1999
|
1489 |
1 |
p. 31-43
13 p.
|
article
|
| 10 |
Morpholino antisense oligomers: the case for an RNase H-independent structural type
|
Summerton, James
|
|
1999
|
1489 |
1 |
p. 141-158
18 p.
|
article
|
| 11 |
Novel mechanisms for antisense-mediated regulation of gene expression
|
Baker, Brenda F
|
|
1999
|
1489 |
1 |
p. 3-18
16 p.
|
article
|
| 12 |
Oligonucleotide N3′→P5′ phosphoramidates as potential therapeutic agents
|
Gryaznov, Sergei M
|
|
1999
|
1489 |
1 |
p. 131-140
10 p.
|
article
|
| 13 |
Oligonucleotide therapeutics for hematologic disorders
|
Agarwal, Neena
|
|
1999
|
1489 |
1 |
p. 85-96
12 p.
|
article
|
| 14 |
Preface
|
Nielsen, P.E
|
|
1999
|
1489 |
1 |
p. 1-
1 p.
|
article
|
| 15 |
Triple helix formation and the antigene strategy for sequence-specific control of gene expression
|
Praseuth, D.
|
|
1999
|
1489 |
1 |
p. 181-206
26 p.
|
article
|
| 16 |
Two problems in antisense biotechnology: in vitro delivery and the design of antisense experiments
|
Stein, C.A
|
|
1999
|
1489 |
1 |
p. 45-52
8 p.
|
article
|
Journal description